Israel Englander Care Dx, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Care Dx, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 450,739 shares of CDNA stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

450,739

Previous 2,140,909 78.95%

Holding current value

$10.1 Million

Previous $33.2 Million 57.68%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$14.41 - $33.99 $24.4 Million - $57.4 Million	-1,690,170 Reduced 78.95%	450,739 $14.1 Million
Q2 2024 Aug 14, 2024	BUY	$7.56 - $16.15 $14.8 Million - $31.7 Million	1,960,308 Added 1085.44%	2,140,909 $33.2 Million
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $616,589 - $958,192	-77,461 Reduced 30.02%	180,601 $1.91 Million
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $565,538 - $1.48 Million	-115,416 Reduced 30.9%	258,062 $3.1 Million
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $10.1 Million - $12.5 Million	-1,326,322 Reduced 78.03%	373,478 $3.17 Million
Q1 2023 May 15, 2023	BUY	$8.83 - $17.61 $8.73 Million - $17.4 Million	988,259 Added 138.89%	1,699,800 $15.5 Million
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $2.18 Million - $4.02 Million	200,672 Added 39.28%	711,541 $8.12 Million
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $160,600 - $263,900	10,000 Added 2.0%	510,869 $8.7 Million
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $2.25 Million - $4.36 Million	-109,857 Reduced 17.99%	500,869 $10.8 Million
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $4.95 Million - $8.18 Million	-175,445 Reduced 22.32%	610,726 $22.6 Million
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $17.8 Million - $31.8 Million	431,521 Added 121.68%	786,171 $35.8 Million
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $11.2 Million - $17.4 Million	-189,512 Reduced 34.83%	354,650 $22.5 Million
Q2 2021 Aug 16, 2021	BUY	$63.02 - $95.11 $30.9 Million - $46.7 Million	490,554 Added 915.08%	544,162 $49.8 Million
Q1 2021 May 17, 2021	SELL	$57.62 - $95.6 $2.04 Million - $3.38 Million	-35,335 Reduced 39.73%	53,608 $3.65 Million
Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $16.3 Million - $30.4 Million	-394,454 Reduced 81.6%	88,943 $6.44 Million
Q3 2020 Nov 16, 2020	BUY	$30.88 - $37.94 $138,064 - $169,629	4,471 Added 0.93%	483,397 $18.3 Million
Q2 2020 Aug 14, 2020	BUY	$18.95 - $35.43 $5.63 Million - $10.5 Million	297,116 Added 163.42%	478,926 $17 Million
Q1 2020 May 14, 2020	SELL	$13.94 - $28.25 $1.59 Million - $3.22 Million	-113,934 Reduced 38.52%	181,810 $3.97 Million
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $3.03 Million - $4.47 Million	157,491 Added 113.92%	295,744 $6.38 Million
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $1.27 Million - $2.53 Million	-63,175 Reduced 31.36%	138,253 $3.13 Million
Q2 2019 Aug 15, 2019	SELL	$25.78 - $39.77 $55.6 Million - $85.7 Million	-2,156,084 Reduced 91.46%	201,428 $7.25 Million
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $58 Million - $89.5 Million	2,250,110 Added 2095.04%	2,357,512 $10 Million
Q1 2019 May 14, 2019	SELL	$22.09 - $39.21 $1.23 Million - $2.18 Million	-55,621 Reduced 34.12%	107,402 $3.39 Million
Q4 2018 Feb 14, 2019	BUY	$19.89 - $30.02 $1.16 Million - $1.75 Million	58,280 Added 55.64%	163,023 $4.1 Million
Q3 2018 Nov 14, 2018	SELL	$12.1 - $28.85 $1.67 Million - $3.98 Million	-137,870 Reduced 56.83%	104,743 $3.02 Million
Q2 2018 Aug 14, 2018	BUY	$7.93 - $15.79 $653,915 - $1.3 Million	82,461 Added 51.49%	242,613 $2.97 Million
Q1 2018 May 15, 2018	BUY	$5.18 - $7.97 $592,146 - $911,082	114,314 Added 249.39%	160,152 $1.28 Million
Q4 2017 Feb 14, 2018	BUY	$3.98 - $7.37 $182,435 - $337,826	45,838	45,838 $336,000

Others Institutions Holding CDNA

# of Institutions

219

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.2B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account